| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 29.9× | −1.7× | |
| Price / Book | 3.5× | 2.0× | |
| Price / Sales | 0.8× | 4.0× | |
| Price / Free cash flow | 22.4× | −1.6× | |
| EV / EBITDA | 18.0× | −1.2× | |
| Earnings yield | 3.3% | −14.6% | |
| Free cash flow yield | 4.5% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,248.83 | −0.65% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.24 | −0.52% | $612.69B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.45 | −0.34% | $502.66B | 119.3× | −129.2% | +26.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.61 | −0.92% | $356.78B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.68 | +0.04% | $278.74B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.14 | −0.16% | $256.12B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $678.88 | −1.61% | $251.01B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.40 | −0.95% | $231.61B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.19 | −0.64% | $192.43B | 22.8× | 37.5% | +32.0% |
ABNYSE:ABTAbbott Laboratories · 🇺🇸 NYSE | $104.24 | −0.62% | $181.57B | 28.0× | 12.5% | −19.0% |
